Transcription of Lymphoma
{{id}} {{{paragraph}}}
Example: tourism industry
Lymphoma
Guideline Resource Unit Lymphoma Clinical Practice Guideline LYHE-002 V16. Table of Contents Background Guideline Questions Search Strategy Target Population Discussion I. Diagnosis and Pathologic Classifications II. Staging III. Treatment of Non-Hodgkin Lymphomas IV. Cutaneous Lymphoma V. Hodgkin Lymphoma VI. HDCT and Hematopoietic Stem Cell Transplantation for Lymphoma VII. Supportive Care in the Treatment of Lymphoma VIII. Follow-Up Care in the Treatment of Lymphoma Appendix A (Chemotherapy Regimens). Appendix B: General Radiotherapy Guidelines Appendix C: Prognostic Models Appendix D: Lymphoma Response Criteria Appendix E: New Lymphoma Patient Data Sheet Appendix F: Ideal Body Weight Glossary of Abbreviations Dissemination Maintenance Clinical Practice Guideline LYHE-002 Background Lymphomas encompass a group of lymphoproliferative malignant diseases that originate from T- and B- cells in the lymphatic system.
Nodular lymphocyte predominant Hodgkin Lymphoma . Mantle cell (can be aggressive) Mycosis fungoides /Sezary syndrome . Primary cutaneous, CD30+ Primary cutaneous perioheral T-cell lymphoma PTCL, CD30- T-cell large granular lymphocytic leukemia . Aggressive Diffuse large B-cell o T-cell/histocyte-rich DLBCL o Primary DLBCL of the CNS
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: